<DOC>
	<DOCNO>NCT02872857</DOCNO>
	<brief_summary>The purpose study examine effect study drug -- Galantamine—on patient subarachnoid hemorrhage ( SAH ) . The study examine patient SAH tolerate study drug may improve brain functioning patient SAH .</brief_summary>
	<brief_title>Subarachnoid Hemorrhage Recovery And Galantamine</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Galantamine</mesh_term>
	<criteria>Spontaneous subarachnoid hemorrhage Presentation hospital within 24 hour symptoms Fisher grade 3 hemorrhage ( thick subarachnoid clot ) initial compute tomography ( CT ) scan Hunt Hess grade 25 time randomization Presence saccular aneurysm compute tomographic angiography ( CTA ) Angiogram clip coil possible Ability obtain medication within 36 hour presentation subarachnoid hemorrhage ( SAH ) due cause aneurysm rupture ( trauma , arteriovenous malformation ( AVM ) , mycotic aneurysm , Moyamoya ) Preexisting disability modify Rankin Scale ( mRS ) score ≥2 , Renal disease define creatinine clearance le 9 milliliters/min History severe hepatic impairment ( ChildPugh score 1015 ) History chronic obstructive pulmonary disease ( COPD ) asthma History dementia Comorbid condition likely complicate therapy , include clinically significant arrhythmia , acquire immune deficiency syndrome ( AIDS ) , autoimmune disease , malignancy , expect mortality within 72 hour Expected mortality within 72 hour determine PI , treat neurointensivist neurosurgeon . ( Clinically manifest attempt secure aneurysm ) Females pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>